FNAC of tubercular lymph node –An alternative to excision biopsy

---

Original Article

Author Details : Sheela Chaudhari, Neha Batra, Deepa Halwal, Sachan Bhat

Volume : 3, Issue : 2, Year : 2016

Article Page : 237-241

Suggest article by email

Get Permission

---

Abstract

Background: Tuberculosis is a major health   problem in our country, India. Tuberculer involvement of cervical lymph node is very common. Diagnosis of tubercular lymphadenitis can be made by using various biochemical, micro bacteriological laboratory methods. Above all these methods stands Fine needle aspiration cytology (FNAC) of affected lymph node which is simple, quick, easy and effective method to diagnose tubercular lymphadenopathy.

Aim: This study is done to

1.        Study various cytological patterns of tubercular lymphadenitis & find out the AFB positivity of such cases.

2.        To find out how far it can obviate the biopsy of tubercular lymph nodes for diagnosis.

Material and Methods: Total 465 suspected cervical tubercular lymphadenopathy patients of were included in study.  Detailed clinical history regarding duration of swelling, sites, size, consistency, and mobility were taken into account. Fine needle aspirations were done and the smears were air-dried and stained with May- Grünwald Giemsa (MGG) and Ziehl-Neelsen (ZN) stain for acid fast bacilli (AFB).
Result: During this period of five years 465 patients of cervical lymphadenopathy were diagnosed as tubercular lymphadenitis. AFB positivity was 55.2%.
Conclusion: FNAC can be used as diagnostic tool alone in case of tubercular lymphadenitis.

Keywords: FNAC, Z-N staining, Tubercular

How to cite : Chaudhari S, Batra N, Halwal D, Bhat S, FNAC of tubercular lymph node –An alternative to excision biopsy. Indian J Pathol Oncol 2016;3(2):237-241

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.